TE
Telomir Pharmaceuticals, Inc. Common Stock
TELO · NASDAQ
$1.16 +1.75% (+$0.02)
1M +0.00%
Market Cap $79.8M
P/E Ratio -
Div. Yield -
ROE 102.69%
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/B 15.85x
P/E N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 120.93%
ROE 102.69%
ROA 109.51%
Debt
69 /100
Low Debt/Equity 0.00x
Current ratio 16.14x
Int. coverage -837.07x
Stability
19 /100
Unstable Beta -0.24x
EPS volatility 829.02%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o TELO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Erez Aminov
Employees
2
Headquarters
Miami
Prihajajoči dogodki
02 DEC.
Earnings
Upcoming earnings report